TP53 and neuroblastoma: Whilst we observed exon skipping of exon 6 of MDM4 mRNA in neuroblastoma cell lines too, our GSK3203591 sensitivity spectrum suggests that p53 activation is not the major determinant of drug sensitivity in MNA neuroblastoma.